PCI The Journeys Within
CPHI 2026 – 23/07/2026
Media Pack
News

Current Edition

JCS - Volume 18 Issue 3 - Autumn 2026
Frankfurt 2027 – 12/10/26
ramusmedical
Europe

Orchard Therapeutics Appoints Jon Ellis to Board of Directors

Boston, USA and London, UK / B3C newswire / -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with r...
22 August 2018 Europe | North America | Regional News
Continue Reading →
Europe

Trailblazing VIARES changes the standards for entry-level CRAs

VIARES is the first independent organization to achieve IAOCR 5 star accreditation for their industry-newcomers training course Maidenhead, United Kingdom and Vienna...
22 August 2018 Europe | news | Regional News
Continue Reading →
Europe

CRF Health Launches Self-Service Model for TrialConsent® Platform

Self-service Version Enables Sponsors and CROs to Take Control of eConsent Technology Plymouth Meeting, PA – 20 August 2018: CRF Health, the leading global provider o...
22 August 2018 Europe | news | Regional News
Continue Reading →
Europe

Benzodiazepines are associated with increased risk of Alzheimer’s disease

The use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer’s disease, according to a recent study from the Univ...
22 August 2018 Europe | news | Regional News
Continue Reading →
news

New technique treats prostate cancer in just five radiotherapy sessions

A new clinical trial shows the benefits of an innovative form of radiation therapy, which delivers the radiation in only five sessions instead of the usual 37. A n...
22 August 2018 news | North America | Regional News
Continue Reading →
news

Endometriosis drug approved by the FDA to reduce pain

A new drug is shown to ease three different types of endometrios Endometriosis is a condition affecting around 1 in 10 women in the United States, and around 200 mill...
22 August 2018 news | North America | Regional News
Continue Reading →
Europe

Europe’s first allogeneic stem cell therapy rejected by NICE

Cost regulators for the NHS in England and Wales have not approved funding for TiGenix and Takeda’s Alofisel - the first allogeneic stem cell therapy to be approved ...
22 August 2018 Europe | news | Regional News
Continue Reading →
news

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease

The U.S. Food and Drug Administration approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary tran...
22 August 2018 news | North America | Regional News
Continue Reading →
news

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound cont...
9 August 2018 news | Regional News
Continue Reading →
news

Quanticate Names David Hukin Senior Director of Pharmacovigilance

London, UK, Quanticate, a leading global data-focused clinical research organisation (CRO) has named David Hukin as the company's new Senior Director of Pharmacovigil...
9 August 2018 news | Regional News
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte